![Michael Gorley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 917 324 $ al 31/05/2026
Michael Gorley is currently the Director of the Fusion Technology Division at UK Atomic Energy Authority since 2024.
Dr. Gorley is also an Independent Non-Executive Director at ASP Isotopes, Inc. since 2023.
Dr. Gorley holds a doctorate from the University of Oxford.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ASP ISOTOPES, INC. 0,09 % | 29/04/2026 | 117.908 ( 0,09 % ) | 917 324 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ASP ISOTOPES INC. | Director/Miembro de la Junta | 19/10/2023 |
UK Atomic Energy Authority
 UK Atomic Energy Authority Alternative Power GenerationUtilities Operates as a holding company with interest in nuclear clean-up services | Corporate Officer/Principal | 01/01/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UK Atomic Energy Authority
UK Atomic Energy Authority Alternative Power GenerationUtilities Operates as a holding company with interest in nuclear clean-up services | Utilities |
ASP Isotopes, Inc.
 ASP Isotopes, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-commercial stage materials company that produces, distributes, markets and sells isotopes | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
